Abstract:BACKGROUND: Ketamine is a kind of frequently used general venous anesthesia drug in clinic, and the medication in vein or epidural cavum has analgesic effect. It is N-methyl-D-aspartic acid (NMDA) receptor noncompetitive antagonist, which can inhibit toxic effect of excitatory amino acids. OBJECTIVE: To observe effect of ketamine on apoptosis of dorsal horn astrocytes of spinal cord of rats induced by NMDA receptor over activation and explore its possible mechanism of action. DESIGN: Randomized controlled observation. SETTING: Department of Anesthesiology, Taihe Hospital Affiliated to Yunyang Medical College. MATERIALS: The experiment was conducted at Cell Biology Laboratory, Institute of Basic Medical Sciences, Yunyang Medical College between September 2003 and January 2005. Neonatal Wistar rats of two or three days were provided by Animal Experimental Center of Wuhan University. METHODS: Primary astrocytes in dorsal horn of T11-L6 spinal cord of Wistar rats were purified and cultured. Astrocytes were used in the experiment when its purity coefficient reached 98% assessed by gial fibrillary acidic protein. The cultured cells in 24-well plates were divided randomly into 6 groups (9 portions in each group): ①50 μL Hanks liquor was added into the control group. ②Amount of 100 μmol/L was added into the NMDA group. ③Amount of 1 mmol/L was added into the ketamine group. ④100 μmol/L NMDA + 0.1 mmol/L ketamine group. ⑤100 μmol/L NMDA + 0.5 mmol/L ketamine group. ⑥100 μmol/L NMDA + 1 mmol/L ketamine group. 1 mmol/L ketamine was clinical antalgic dosage. Activity of superoxide dismutase (SOD) and content of malondialdehyde (MDA) were examined after 24-hour culture. Content of Bcl-2 protein and change of morphology were observed with immunocytochemistry. Apoptosis of astrocytes was measured with flow cytometry. MAIN OUTCOME MEASURES: ①Counterstain cell staining and changes of morphology of Bcl-2 protein with immunohistochemical method and hematoxylin-esoin staining (HE). ②Apoptosis of astrocytes was detected with flow cytometry. ③Content of MDA and activity of SOD. RESULTS: ①Mean absorbance (A) of Bcl-2 as expression of Bcl-2 protein measured semiquantitatively: It was lower in the 100 μmol/L NMDA group than the control group, which had significant difference [0.054±0.021, 0.108±0.039, respectively, P < 0.01]. It was higher in the 100 μmol/L NMDA + 1 mmol/L ketamine group than the 100 μmol/L NMDA group, which had significant difference [0.148±0.045, 0.054±0.021, respectively, P < 0.01]. ②Apoptosis of astrocytes detected with flow cytometry: It was higher in the 100 μmol/L NMDA group than the control group, which had significant difference [(25.26±6.13)%,(5.66±2.24)%, respectively, P < 0.01]. It was lower in the 100 μmol/L NMDA + 1 mmol/L ketamine group than in the 100 μmol/L NMDA group, which had significant difference [(24.41±4.82)%,(25.26±6.13)%, respectively, P < 0.01]. ③Content of MDA and activity of SOD: 100 μmol/L NMDA made the content of MDA in astrocytes obviously increase , while the activity of SOD markedly decrease. 1 mmol/L ketamine remarkably decreased the content of MDA, distinctly increased the activity of SOD. This effectiveness had evidently dosage-effect relationship in clinical antalgic dosage, which had obviously difference as compared with that of the NMDA group (P < 0.01). The differences between the 1 mmol/L ketamine group and the control group as well as between the 100 μmol/L NMDA + 0.1 mmol/L ketamine group and the NMDA group had insignificant difference. CONCLUSION: NMDA receptor over activation can induce apoptosis of a great number of astrocytes in spinal dorsal horn of rats. Suitable ketamine dramatically inhibits apoptosis, and its mechanism can enhance the expression of Bcl-2 protein of astrocytes, at the same time inhibit the production of free radical and reinforce the activity of SOD.

Administration of low dose intranasal ketamine exerts a neuroprotective effect on whole brain irradiation injury model in wistar rats

Ketamine Decreases Cerebral Infarct Volume and Improves Neurological Outcome Following Experimental Head Trauma in Rats

Mechanisms of Propofol Attenuation of Ketamine-Induced Neonatal Brain Injury

Low‐dose ketamine improves animals' locomotor activity and decreases brain oxidative stress and inflammation in ammonia‐induced neurotoxicity

Effect of Ketamine Anesthesia on Cognitive Function and Immune Function in Young Rats.

Protective Effect of Ketamine on Ischemic Spinal Cord Injury in Rabbits

Ketamine-induced Neuronal Damage and Altered N-methyl-D-aspartate Receptor Function in Rat Primary Forebrain Culture.

Stress and Ketamine, Bimodal Influence on Cognitive Functions

Pretreatment with Minocycline Restores Neurogenesis in the Subventricular Zone and Subgranular Zone of the Hippocampus after Ketamine Exposure in Neonatal Rats.

MPTP-induced dopaminergic neurotoxicity in mouse brain is attenuated after subsequent intranasal administration of (R)-ketamine: a role of TrkB signaling

Neuronal injury, but not microglia activation, is associated with ketamine-induced experimental schizophrenic model in mice.

Influence of ketamine on astrocyte damage in spinal dorsal horn of rats induced by N-methyl-D-aspartic acid

N-acetylcysteine Relieves Oxidative Stress and Protects Hippocampus of Rat from Radiation-Induced Apoptosis by Inhibiting Caspase-3

Evaluation of the neuroprotective effect of quercetin against damage caused by gamma radiation

Dual Effects of Ketamine

Ketamine enhances novel object recognition memory reconsolidation via the BDNF/TrkB pathway in mice

Repeated Administration of Ketamine Can Induce Hippocampal Neurodegeneration and Long-Term Cognitive Impairment Via the ROS/HIF-1α Pathway in Developing Rats

17Β-Estradiol Treatment Attenuates Neurogenesis Damage and Improves Behavior Performance after Ketamine Exposure in Neonatal Rats

Acute administration of ketamine in rats increases hippocampal BDNF and mTOR levels during forced swimming test.

Minocycline Ameliorates Cognitive Impairment Induced by Whole-Brain Irradiation: an Animal Study

Neuroprotective effect of ketamine against TNF--induced necroptosis in hippocampal neurons